Treatment of NOD mice with an IGF-I/IGFBP3 complex protects against type 1 diabetes

被引：0
|
作者：
Chen, W [1 ]
Salojin, K [1 ]
Zucker, P [1 ]
Delovitch, TL [1 ]
机构：
[1] John P Robarts Res Inst, London, ON N6G 2V4, Canada
来源：
FASEB JOURNAL | 2002年 / 16卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1046 / A1046
页数：1
相关论文
共 50 条
  • [21] 血清IGF-I和IGFBP3在检测女童性早熟中的意义
    崔朝晖
    黄建荣
    王继东
    束琴华
    许琦
    中国儿童保健杂志, 2002, (05) : 297 - 299
  • [22] Maternal exposure to UV filters: associations with maternal thyroid hormones, IGF-I/IGFBP3 and birth outcomes
    Krause, M.
    Frederiksen, H.
    Sundberg, K.
    Jorgensen, F. S.
    Jensen, L. N.
    Norgaard, P.
    Jorgensen, C.
    Ertberg, P.
    Petersen, J. H.
    Feldt-Rasmussen, U.
    Juul, A.
    Drzewiecki, K. T.
    Skakkebaek, N. E.
    Andersson, A. M.
    ENDOCRINE CONNECTIONS, 2018, 7 (02) : 334 - 346
  • [23] IGFBP3 AND IGF-I GENERATION FOLLOWING GROWTH-HORMONE STIMULATION AS A LIVER ENDOCRINE RESERVE TEST
    BARUCH, Y
    NIMER, A
    AMIT, T
    SHENORR, Z
    HOCHBERG, Z
    HEPATOLOGY, 1994, 20 (04) : A330 - A330
  • [24] Evaluation of disease activity by IGF-I and IGF binding protein-3 (IGFBP3) in acromegaly patients distributed according to a clinical score
    Jasper, H
    Pennisi, P
    Vitale, M
    Mella, A
    Ropelato, G
    Chervin, A
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1999, 22 (01) : 29 - 34
  • [25] Evaluation of disease activity by IGF-I and IGF binding protein-3 (IGFBP3) in acromegaly patients distributed according to a clinical score
    H. Jasper
    P. Pennisi
    M. Vitale
    A. Mella
    G. Ropelato
    A. Chervin
    Journal of Endocrinological Investigation, 1999, 22 : 29 - 34
  • [26] Treatment with insulin lispro changes the insulin profile but does not affect the plasma concentrations of IGF-I and IGFBP-1 in type 1 diabetes
    Hedman, CA
    Orre-Pettersson, AC
    Lindström, T
    Arnqvist, HJ
    CLINICAL ENDOCRINOLOGY, 2001, 55 (01) : 107 - 112
  • [27] Verapamil Prevents Decline of IGF-I in Subjects With Type 1 Diabetes and Promotes β-Cell IGF-I Signaling
    Xu, Guanlan
    Chen, Junqin
    Lu, Brian
    Sethupathy, Praveen
    Qian, Wei-Jun
    Shalev, Anath
    DIABETES, 2023, 72 (10) : 1460 - 1469
  • [28] Circulating IGF-I and IGFBP3 Levels Control Human Colonic Stem Cell Function and Are Disrupted in Diabetic Enteropathy
    D'Addio, Francesca
    La Rosa, Stefano
    Maestroni, Anna
    Jung, Peter
    Orsenigo, Elena
    Ben Nasr, Moufida
    Tezza, Sara
    Bassi, Roberto
    Finzi, Giovanna
    Marando, Alessandro
    Vergani, Andrea
    Frego, Roberto
    Albarello, Luca
    Andolfo, Annapaola
    Manuguerra, Roberta
    Viale, Edi
    Staudacher, Carlo
    Corradi, Domenico
    Batlle, Eduard
    Breault, David
    Secchi, Antonio
    Folli, Franco
    Fiorina, Paolo
    CELL STEM CELL, 2015, 17 (04) : 486 - 498
  • [29] IGF-I receptor expression is negatively regulated by growth factors (IGF-I and TGF-β1) and IGF-binding proteins (IGFBP-3 and IGFBP-5).
    Kuemmerle, JF
    GASTROENTEROLOGY, 2001, 120 (05) : A509 - A509
  • [30] IGF-I/IGFBP3/ALS Deficiency in Sarcopenia: Low GHBP Suggests GH Resistance in a Subgroup of Geriatric Patients
    Ferrari, Uta
    Schmidmaier, Ralf
    Jung, Theresa
    Reincke, Martin
    Martini, Sebastian
    Schoser, Benedikt
    Bidlingmaier, Martin
    Drey, Michael
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (04): : E1698 - E1707
12345